PATENT CLAIM ANALYSIS

Application Number: 15774163
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "186100"]

Abstract:
Provided herein are methods of treating cancer by activating resident memory T cells using one or more antigenic peptides.

Claim (Index 13):
The method of  claim 1 , wherein the adjuvant comprises at least twenty antigenic peptides.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13324887', '14453410', '11556678', '11999509', '10571716']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7333890537997241
- 35 USC 102 Novelty (BERT): 0.4779224963408799
- Combined Prediction Score: 0.7078423980538397
- Mean Citation Score: 210.495296
- Max Citation Score: 214.9942
- Similarity Product: 178.5936786099315

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test